CD79A and acquired epidermolysis bullosa: However, it IgA-EBA may also develop into a more severe clinical manifestation, especially with scarring at mucosal sites, as reported in 30% of the 82 cases in the Vodegel literature review, including 4% with severe ocular involvement (16, 19, 67, 68).